Compromised CDK12 activity causes dependency on the non-essential spliceosome components
Pallasaho, S.; Gondane, A.; Duveau, D.; Thomas, C.; Loda, M.; Itkonen, H. M.
Show abstract
Prostate cancer (PC) is the most common cancer in men and after development of the castration-resistant PC (CRPC), there are no curative treatment options. Inactivating mutations in cyclin-dependent kinase 12 (CDK12) define an aggressive sub-type of CRPC. We hypothesized that compromised CDK12 activity leads to significant rewiring of the CRPC cells, and that this rewiring results in actionable synthetic lethal interactions. MethodsWe used combinatorial lethal screening, ChIP-seq data, RNA-seq data, global alternative splicing analysis, and comprehensive mass spectrometry (MS) profiling to understand how the compromised CDK12 activity rewires the CRPC cells. In addition, we used DepMap-, PC- and CRPC-datasets as a strategy to identify factors that are selectively required by the CDK12-mutant cells. ResultsWe show that inhibition of O-GlcNAc transferase (OGT) and CDK12 induces cancer cell-selective growth-defect. OGT catalyzes all nucleocytoplasmic O-GlcNAcylation, and we use unbiased MS-profiling to show that the short-term CDK12 inhibition induces hyper-O-GlcNAcylation of the spliceosome-machinery in PC and CRPC cells. Integration of DepMap- and a small scale-drug screen data reveled that depletion of CDK12 activity causes addiction to non-essential spliceosome components (CLK1/4 and SRPK1). CDK12-mutant tumors overexpress CLK1/4 and SRPK1. Finally, we show that the genomes of the CDK12-mutant tumors have lower DNA methylation, and that CDK12 inhibition induces the expression of the genes marked by DNA methylation. ConclusionsCompromised CDK12 activity rewires DNA methylation, transcription and splicing, and this rewiring renders the affected cells addicted on the non-essential spliceosome components. We propose that inactivation of CDK12 is a biomarker for sensitivity against inhibitors of the non-essential spliceosome components just entering the clinical trials. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=85 SRC="FIGDIR/small/470703v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@a128e8org.highwire.dtl.DTLVardef@84a70dorg.highwire.dtl.DTLVardef@f37b10org.highwire.dtl.DTLVardef@1145f1b_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A survey of human cancer-germline genes: linking X chromosome localization, DNA methylation and sex-biased expression in early embryos 94%
- Genomic features underlie the co-option of SVA transposons as cis-regulatory elements in human pluripotent stem cells 93%
- The MOV10 RNA helicase is a dosage-dependent host restriction factor for LINE1 retrotransposition in mice 93%
Similar papers in this journal
- Androgen Receptor Signaling Regulates the Transcriptome of Prostate Cancer Cells by Modulating Global Alternative Splicing 96%
- ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis 95%
- MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity 94%
Similar papers in this journal
- Big fish, little fish: N-terminal acetyltransferase Naa40p proteoforms caught in the act 92%
- Evolution of resistance to Irinotecan in cancer cells involves generation of topoisomerase-guided mutations in non-coding genome that reduce the chances of DNA breaks 92%
- The Exon Junction Complex Core Represses Caner-specific Mature mRNA Re-splicing: A Potential Key Role in Terminating Splicing 92%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.